Cargando…
COVID-19 mRNA vaccines
The ongoing COVID-19 pandemic and its unprecedented global societal and economic disruptive impact highlight the urgent need for safe and effective vaccines. Taking substantial advantages of versatility and rapid development, two mRNA vaccines against COVID-19 have completed late-stage clinical asse...
Autores principales: | Huang, Qingrui, Zeng, Jiawei, Yan, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Institute of Genetics and Developmental Biology, Chinese Academy of Sciences, and Genetics Society of China. Published by Elsevier Limited and Science Press.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7959685/ https://www.ncbi.nlm.nih.gov/pubmed/34006471 http://dx.doi.org/10.1016/j.jgg.2021.02.006 |
Ejemplares similares
-
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
por: Zeng, Jiawei, et al.
Publicado: (2023) -
COVID‐19 mRNA vaccines and myopericarditis
por: Gnanenthiran, Sonali R., et al.
Publicado: (2022) -
SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021) -
mRNA vaccines for COVID-19 and diverse diseases
por: Hussain, Abid, et al.
Publicado: (2022) -
Advances in COVID-19 mRNA vaccine development
por: Fang, Enyue, et al.
Publicado: (2022)